References
- Effah CY, Sun T, Liu S, Wu Y. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob. 2020; 19: 1.
- Hansen DS, Gottschau A, Kolmos HJ. Epidemiology of Klebsiella bacteraemia: A case control study using Escherichia coli bacteraemia as control. J Hosp Infect. 1998; 38: 119–132.
- Wyres KL, Holt KE. Klebsiella pneumoniae Population genomics and antimicrobial-resistant clones. Trends Microbiol. 2016; 24: 944–956.
- Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009; 53: 5046–5054.
- Wyres KL, Holt KE. Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr Opin Microbiol. 2018; 45: 131–139.
- Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol. 2011; 19: 588–595.
- Wu W, Feng Y, Tang G, Qiao F, McNally A, Zong Z. NDM Metallo-beta-lactamases and their bacterial producers in health care settings. Clin Microbiol Rev. 2019; 32: e00115–18.
- Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10: 597–602.
- Report of the National Reference Center for Antimicrobial Susceptibility Occurrence of Enterobacteriaceae (Klebsiella pneumoniae) producing New Delhi-type carbapenemases in Poland in Q1 2017. Regional strategy to control the spread of Carbapenemase-Producing Enterobacteriaceae (CPE) by Carbapenemase-Producing Enterobacteriaceae. http://antybiotyki.edu.pl/wp-content/uploads/dokumenty/NDM_Raport_I_kwartal_2017-05-07-1.pdf (24.06.2021).
- Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: A potential threat. JAMA. 2008; 300: 2911–2913.
- Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: The quiet before the storm? Clin Microbiol Rev. 2005; 18: 306–325.
- Surveillance of antimicrobial resistance in Europe 2017. https://www.ecdc.europa.eu/sites/portal/files/documents/AMR-surveillance-EARS-Net-2017.pdf (26.05.2021).
- Provincial Sanitary and Epidemiological Station in Warsaw: Sanitary State of the Masovian Voivodeship 2018; 03.2019. http://wsse.waw.pl/files/wsse/pliki_WSSE/Organizacyjny_2019/Stan_sanitarny_woj.mazowieckiego_2018r.pdf (24.06.2021).
- Temkin E, Adler A, Lerner A, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: Biology, epidemiology, and management. Ann N Y Acad Sci. 2014; 1323: 22–42.
- Richter SS, Marchaim D. Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How? Virulence. 2017, 8: 417–426.
- Jamal AJ, Garcia-Jeldes F, Baqi M, Borgia S, Johnstone J, Katz K, Kohler P, Muller MP, McGeer AJ, Network CPEIotTIBD. Infection prevention and control practices related to carbapenemase-producing Enterobacteriaceae (CPE) in acute-care hospitals in Ontario, Canada. Infect Control Hosp Epidemiol. 2019; 40: 1006–1012.
- Schneider A, Coope C, Michie S, Puleston R, Hopkins S, Oliver I. Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: A qualitative evaluation. BMC Health Serv Res. 2019; 19: 689.
- Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17: 1791–1798.
- Kang H, Zheng W, Kong Z, Jiang F, Gu B, Ma P, Ma X. Disease burden and molecular epidemiology of carbapenem-resistant Klebsiella pneumonia infection in a tertiary hospital in China. Ann Transl Med. 2020; 8: 605.
- Stejakowska A. Analysis of epidemic centres reported to the District Sanitary and Epidemiological Station in Poznan in 2008–2012. Probl Hig Epidemiol. 2014; 95: 854–860.
- Bandoła K, Seweryn M, Koperny M, Bała M, Mikos M. Hospital infection outbreaks in the Malopolska province in 2011–2013. Zdrowie Publiczne i Zarządzanie. 2014, 12.
- The epidemiology of bacteria resistant to antibiotics in the Lubelskie Voivodeship. PSES Lublin 2019. https://www.lublin.uw.gov.pl/sites/default/files/zdrowie/2.%20Sytuacja%20epidemiologiczna%20bakterii%20oprnych%20na%20antybiotyki%20w%20woj.%20lubel-skim.pdf (28.06.2021).
- Report of the Supreme Chamber of Control (NIK). Infections in medical entities. https://www.nik.gov.pl/plik/id,16720,vp,19276.pdf (24.06.2021).
- European Center for Diseases Control and Prevention (ECDC): Healthcare-associated infections in acute care hospitals. https://www.ecdc.europa.eu/en/healthcare-associated-infections-acute-care-hospitals (02.07.2021).
- Otter JA, Burgess P, Davies F, Mookerjee S, Singleton J, Gilchrist M, Parsons D, Brannigan ET, Robotham J, Holmes AH. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: An economic evaluation from a hospital perspective. Clin Microbiol Infect. 2017; 23: 188–196.
- Tansarli GS, Karageorgopoulos DE, Kapaskelis A, Falagas ME. Impact of antimicrobial multidrug resistance on inpatient care cost: An evaluation of the evidence. Expert Rev Anti Infect Ther. 2013; 11: 321–331.
- Tischendorf J, de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review. Am J Infect Control. 2016; 44: 539–543.
- Pano Pardo JR, Serrano Villar S, Ramos Ramos JC, Pintado V. Infections caused by carbapenemase-producing Enterobacteriaceae: Risk factors, clinical features and prognosis. Enferm Infecc Microbiol Clin. 2014; 32, Suppl 4: 41–48.